Article
Licensed
Unlicensed
Requires Authentication
Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
-
Athina Markou
and
Evi Lianidou
Published/Copyright:
July 18, 2011
Abstract
Non-small cell lung carcinomas (NSCLC) account for about 80% of lung cancers and their remarkable heterogeneity manifests in histology, pathogenesis, prognosis, and response to treatments. Recent advances in molecular characterization help stratifying NSCLC patients for their potential benefit from targeting therapies. However, the fundamental mechanisms underlying the tumoral heterogeneity remain poorly understood. Expression profiling of many microRNAs (miRNAs) in various normal and disease tissues demonstrated unique spatial and temporal expression patterns and some miRNAs have been functionally characterized as oncogenes or tumor suppressor genes. Genome-wide screening identified specific miRNA expression signatures associated with clinical outcome of NSCLC patients. A group of miRNAs that has enriched expression in normal lung was found down regulated in NSCLC and may function as tumor suppressor genes. In this review we: a) summarize the current understanding of the critical role that miRNAs play in normal cell functions and in disease biology especially in lung cancer tumorigenesis, b) highlight their potential as biomarkers for lung cancer risk stratification, outcome prediction and classification of histologic subtypes, c) critically assess current knowledge on lung-enriched miRNAs and expression of their predicted target genes in NSCLC and d) evaluate their potential as circulating biomarkers and therapeutic targets in lung cancer.
Received: 2011-3-17
Accepted: 2011-6-2
Published Online: 2011-07-18
Published in Print: 2011-10-01
©2011 by Walter de Gruyter Berlin Boston
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Editorial
- Laboratory medicine: an essential partner in the care of cancer patients
- Reviews
- Circulating tumor cells as emerging tumor biomarkers in breast cancer
- Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
- Increased plasma concentrations of tumour markers in the absence of neoplasia
- Recent progress and clinical importance on pharmacogenetics in cancer therapy
- Genetics and Molecular Diagnostics
- Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument
- General Clinical Chemistry and Laboratory Medicine
- Mapping point-of-care performance using locally-smoothed median and maximum absolute difference curves
- The use of inflammatory markers as a method for discharging patients post hip or knee arthroplasty
- Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease
- Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women
- Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study
- Comparative evaluation of capillary zone electrophoresis and HPLC in the determination of carbohydrate-deficient transferrin
- Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
- Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples
- Diagnostic utility of a soluble cytokeratin 18 assay for gastrointestinal graft-vs.-host disease detection
- Cancer Diagnostics
- The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer
- Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
- Serum APRIL, a potential tumor marker in pancreatic cancer
- Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
- Infectious Diseases
- New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
- Cardiovascular Diseases
- Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese Population
- Diabetes
- Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia
- A simple micro-photometric method for urinary iodine determination
- Letters to the Editor
- Clinically needed sensitivity for very low levels of Factor XIII: not yet proven for a new functional assay
- Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations
- Congress Abstracts
- 10.1515/CCLM.2011.738
- 1st National Congress of Laboratory Medicine
Keywords for this article
diagnosis;
microRNAs;
non-small cell lung cancer;
prognosis;
tumor biomarkers
Articles in the same Issue
- Editorial
- Laboratory medicine: an essential partner in the care of cancer patients
- Reviews
- Circulating tumor cells as emerging tumor biomarkers in breast cancer
- Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
- Increased plasma concentrations of tumour markers in the absence of neoplasia
- Recent progress and clinical importance on pharmacogenetics in cancer therapy
- Genetics and Molecular Diagnostics
- Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument
- General Clinical Chemistry and Laboratory Medicine
- Mapping point-of-care performance using locally-smoothed median and maximum absolute difference curves
- The use of inflammatory markers as a method for discharging patients post hip or knee arthroplasty
- Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease
- Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women
- Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study
- Comparative evaluation of capillary zone electrophoresis and HPLC in the determination of carbohydrate-deficient transferrin
- Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
- Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples
- Diagnostic utility of a soluble cytokeratin 18 assay for gastrointestinal graft-vs.-host disease detection
- Cancer Diagnostics
- The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer
- Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
- Serum APRIL, a potential tumor marker in pancreatic cancer
- Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
- Infectious Diseases
- New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
- Cardiovascular Diseases
- Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese Population
- Diabetes
- Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia
- A simple micro-photometric method for urinary iodine determination
- Letters to the Editor
- Clinically needed sensitivity for very low levels of Factor XIII: not yet proven for a new functional assay
- Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations
- Congress Abstracts
- 10.1515/CCLM.2011.738
- 1st National Congress of Laboratory Medicine
